How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Tubular Metal Biliary Stents Market
- By Material Type: Stainless Steel, Nitinol (Nickel-Titanium Alloy), Cobalt-Chromium Alloy, Polymer-Coated Metal
- By Stent Design: Uncovered (Bare Metal) Stents, Partially Covered Stents, Fully Covered Stents
- By Indication: Malignant Biliary Obstruction, Benign Biliary Strictures, Post-Surgical Biliary Leaks
- By Diameter Size: 6-8 mm, 8-10 mm, 10-12 mm
- By Length: Short (≤40 mm), Medium (41-80 mm), Long (>80 mm)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Stainless Steel leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Tubular Metal Biliary Stents Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Material Type 4
Stent Design 3
Indication 3
Diameter Size 3
Length 3
Companies profiled
Boston Scientific Corporation
Cook Medical (a subsidiary of Cook Group)
Medtronic plc
Stryker Corporation
Becton
Dickinson and Company (BD)
C.R. Bard
Inc. (now part of BD)
Taewoong Medical Co. Ltd.
M.I. Tech Co. Ltd.
Niti-S (a brand by Taewoong Medical)
Leufen Medical GmbH
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cook Medical (a subsidiary of Cook Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →C.R. Bard
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Inc. (now part of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Taewoong Medical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →M.I. Tech Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Niti-S (a brand by Taewoong Medical)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Leufen Medical GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →EndoChoice Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Merit Medical Systems Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Micro-Tech Endoscopy USA Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Olympus Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,836M by 2033 · 3.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Stainless Steel54.6
- Nitinol (Nickel-Titanium Alloy)22.0
- Cobalt-Chromium Alloy14.6
- Polymer-Coated Metal8.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,703M → $2,500M · 4.9%
Europe$1,187M → $1,695M · 4.6%
Asia Pacific$1,083M → $1,470M · 3.9%
Latin America$670.7M → $994.8M · 5.1%
Middle East and Africa$515.9M → $624.0M · 2.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.542026
3.552027
3.552028
3.572029
3.592030
3.602031
3.602032
3.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Boston Scientific Corporation24.9
- Cook Medical (a subsidiary of Cook Group)13.7
- Medtronic plc9.7
- Stryker Corporation10.7
- Becton4.0
- Dickinson and Company (BD)9.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type9.5%
Stent Design28.0%
Indication27.2%
Diameter Size21.9%
Length13.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe23.3
- Asia Pacific20.2
- Latin America13.7
- Middle East and Africa8.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 94 | 91 | 83 | 82 | 78 | 78 | 84 |
| Cook Medical (a subsidiary of Cook Group) | 72 | 83 | 89 | 78 | 84 | 89 | 83 |
| Medtronic plc | 86 | 87 | 84 | 78 | 79 | 86 | 83 |
| Stryker Corporation | 73 | 73 | 58 | 78 | 77 | 58 | 70 |
| Becton | 58 | 64 | 53 | 67 | 62 | 55 | 60 |
| Dickinson and Company (BD) | 60 | 58 | 70 | 69 | 71 | 68 | 66 |
| C.R. Bard | 51 | 40 | 59 | 41 | 59 | 46 | 49 |
| Inc. (now part of BD) | 37 | 41 | 42 | 52 | 45 | 53 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Boston Scientific Corporation
- Cook Medical (a subsidiary of Cook Group)
- Medtronic plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Cook Medical (a subsidiary of Cook Group) | ◐ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Medtronic plc | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Stryker Corporation | ✓ | ✓ | − | ◐ | ◐ | ◐ |
| Becton | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Dickinson and Company (BD) | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| C.R. Bard | − | − | ◐ | − | ◐ | ◐ |
| Inc. (now part of BD) | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Boston Scientific Corporation84
2Cook Medical (a subsidiary of Cook Group)83
3Medtronic plc83
4Stryker Corporation70
5Dickinson and Company (BD)66
6Becton60
7C.R. Bard49
8Inc. (now part of BD)45
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Boston Scientific CorporationCook Medical (a subsidiary of Cook Group)Medtronic plc
Challenger1
Strong scale, closing on the leaders.
Stryker Corporation
Contender2
Focused players with pockets of strength.
BectonDickinson and Company (BD)
Niche2
Specialists in a single segment or region.
C.R. BardInc. (now part of BD)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Tubular Metal Biliary Stents Market — a $137M beachhead inside a $2.09B market.
Beachhead (SOM)$137Mobtainable near-term
Serviceable (SAM)$778Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Stainless Steel
Best fit — highest urgency & budget in Material Type.
Economic buyer76 fit
Nitinol (Nickel-Titanium Alloy)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Cobalt-Chromium Alloy
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Stent Design & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Indication
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel27%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tubular Metal Biliary Stents Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified22%
Evaluation12%
Closed-won8%
$8.1KCAC
$46KLTV
5.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Tubular Metal Biliary Stents Market is a high-growth opportunity — $5.41B by 2033, compounding at 10.5%.
TAM · 2025$2.44Btoday
TAM · 2033$5.41Bforecast
CAGR10.5%2027–2033
Cumulative$33.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.41BTotal addressable market
SAM$1.89BServiceable available market
SOM$367MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.5% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.41BLarge & growingTAM by 2033 at 10.5% CAGR
$1.89BServiceable nowreachable with today’s model
$367MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.22BBear6.8% CAGR
$5.41BBase10.5% CAGR
$6.92BBull13.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Stent Design optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Tubular Metal Biliary Stents Market — a $5.09B market by 2033. Plan: grow share from 10.2% to 15.8%.
Market size · 2033$5.09Btotal addressable
Market CAGR3.6%2027–2033
Target share15.8%from 10.2% today
Revenue ambition$805Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.2% | 15.8% | Ahead |
| Revenue | $539M | $805M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 33.8% | 39.2% | On track |
| Customer retention | 88.1% | 93.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Stent Design capability
A defensible second engine — invest in Stent Design to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Stent Design
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $90M capacity & capability investment
- Greenlight bolt-on M&A in Stent Design
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Tubular Metal Biliary Stents Market conversation — a $6.76B market you can size, segment and defend in minutes.
Market size · 2033$6.76Btotal opportunity
Growth5.1%CAGR to 2033
Addressable buyers1,564+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 3 mopayback period
$82K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Boston Scientific CorporationCook Medical (a subsidiary of Cook Group)Medtronic plcStryker CorporationBectonDickinson and Company (BD)C.R. BardInc. (now part of BD)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tubular Metal Biliary Stents Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tubular Metal Biliary Stents Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Tubular Hemorrhoid Stapler Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTubular Glass Vials Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportTubular External Fixation System Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportTubular Elastic Bandage Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportTubular Ear Syringe Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportTube Thoracostomy Market
Market size, share, segmentation and regional forecast.
$499M market · 2025 base year
View reportTuberous Sclerosis Drug Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportTuberculosis Vaccine Drug Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportTuberculosis Vaccination Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportTuberculosis Testing and Diagnostics Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportTuberculosis (TB) Detection Market
Market size, share, segmentation and regional forecast.
$984M market · 2025 base year
View reportTuberculosis Screening Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.